These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38182479)

  • 41. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.
    Adam R
    Ann Oncol; 2003; 14 Suppl 2():ii13-6. PubMed ID: 12810452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Colorectal cancer].
    Oya M; Sameshima S; Tagaya N; Takeshita E; Koketsu S; Sugamata Y; Yoshiba H; Ueno M; Fujimoto Y; Suenaga M
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1252-5. PubMed ID: 21829061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Is preoperative systemic chemotherapy recommended for resectable colorectal liver metastases? Oncosurgical aspects].
    Dede K; Póti Z; Bursics A
    Orv Hetil; 2018 May; 159(21):823-830. PubMed ID: 29779391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
    Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
    Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal metastases to the liver: present results and future strategies.
    Lise M; Da Pian PP; Nitti D; Pilati PL
    J Surg Oncol Suppl; 1991; 2():69-73. PubMed ID: 1832542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neoadjuvant chemotherapy in the management of colorectal metastases: A review of the literature.
    Ong SY
    Ann Acad Med Singap; 2003 Mar; 32(2):205-11. PubMed ID: 12772524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
    Bolhuis K; Kos M; van Oijen MGH; Swijnenburg RJ; Punt CJA
    Eur J Cancer; 2020 Dec; 141():225-238. PubMed ID: 33189037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
    Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
    Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
    Ke S; Zhan S; Zhu H; Yan D
    J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
    Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
    Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Liver transplantation for non-resectable colorectal liver metastases: A review].
    García D; Rebolledo P; Achurra P; Briceño E; Viñuela E; Mondaca S; Arab JP; Martínez J; Nervi B; Dib M
    Rev Med Chil; 2022 May; 150(5):656-663. PubMed ID: 37906767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review.
    Link KH; Kornmann M; Formentini A; Leder G; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Langenbecks Arch Surg; 1999 Aug; 384(4):344-53. PubMed ID: 10473854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.
    Ji JH; Park SH; Lee J; Kim TW; Hong YS; Kim KP; Kim SY; Baek JY; Kang HJ; Shin SJ; Shim BY; Park YS
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):223-30. PubMed ID: 23689915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.
    Lim E; Thomson BN; Heinze S; Chao M; Gunawardana D; Gibbs P
    ANZ J Surg; 2007 Nov; 77(11):941-7. PubMed ID: 17931254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.
    Lucidi V; Hendlisz A; Van Laethem JL; Donckier V
    World J Gastroenterol; 2016 Apr; 22(15):3937-44. PubMed ID: 27099436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
    Ruers TJ; Joosten JJ; Wiering B; Langenhoff BS; Dekker HM; Wobbes T; Oyen WJ; Krabbe PF; Punt CJ
    Ann Surg Oncol; 2007 Mar; 14(3):1161-9. PubMed ID: 17195903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.